Back to Search
BENJAMIN LEDER, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1982783924IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
152510(MA)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
152510(MA)
Education
HARVARD MEDICAL SCHOOL
Class of 1994
Clinical Trials (4)
4
Linked Trials
1
Recruiting
2
With Results
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
NCT04026256COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
NCT02176382COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Combined Anabolic Therapy
NCT06558188RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
PMID 32790196·J Bone Miner Res·2021
2-rct
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
PMID 31674641·J Clin Endocrinol Metab·2020
2-rct
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.
PMID 31447409·Lancet Diabetes Endocrinol·2019
2-rct
Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.
PMID 19435827·J Clin Endocrinol Metab·2009
8-other
Gonadal steroids and bone metabolism in men.
PMID 17940446·Curr Opin Endocrinol Diabetes Obes·2007
6-review
Is parathyroid hormone (1-84) a safe and effective treatment for postmenopausal osteoporosis?
PMID 17768406·Nat Clin Pract Endocrinol Metab·2007
8-other
Racial and ethnic differences in bone turnover markers in men.
PMID 17579203·J Clin Endocrinol Metab·2007
4-observational
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
PMID 15856361·Osteoporos Int·2005
2-rct
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
PMID 15001605·J Clin Endocrinol Metab·2004
3-trial
Differential effects of androgens and estrogens on bone turnover in normal men.
PMID 12519853·J Clin Endocrinol Metab·2003
3-trial
Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.
PMID 12466335·J Clin Endocrinol Metab·2002
3-trial
Metabolism of orally administered androstenedione in young men.
PMID 11502792·J Clin Endocrinol Metab·2001
3-trial
Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
PMID 11158001·J Clin Endocrinol Metab·2001
3-trial
Oral androstenedione administration and serum testosterone concentrations in young men.
PMID 10683057·JAMA·2000
3-trial
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
PMID 19671656·N Engl J Med·2009
4-observational
Patient information page from the Hormone Foundation. High blood calcium (Hypercalcemia).
PMID 19593858·J Clin Endocrinol Metab·2009
8-other
Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men.
PMID 19419295·J Bone Miner Res·2009
3-trial
Effects of teriparatide retreatment in osteoporotic men and women.
PMID 19401368·J Clin Endocrinol Metab·2009
3-trial
Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength.
PMID 19106273·J Clin Endocrinol Metab·2009
8-other
Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
PMID 18616708·Clin Endocrinol (Oxf)·2009
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 PARKMAN STREET WAC 730S, ENDOCRINE ASSOCIATES
BOSTON, MA 02114 - Phone
- (617) 726-8720
Quick Facts
- NPI
- 1982783924
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile